...
首页> 外文期刊>Health Research Policy and Systems >Evidence-based policymaking is not like evidence-based medicine, so how far should you go to bridge the divide between evidence and policy?
【24h】

Evidence-based policymaking is not like evidence-based medicine, so how far should you go to bridge the divide between evidence and policy?

机译:循证决策与循证医学不同,您应该走多远才能弥合证据与政策之间的鸿沟?

获取原文
   

获取外文期刊封面封底 >>

       

摘要

There is extensive health and public health literature on the ‘evidence-policy gap’, exploring the frustrating experiences of scientists trying to secure a response to the problems and solutions they raise and identifying the need for better evidence to reduce policymaker uncertainty. We offer a new perspective by using policy theory to propose research with greater impact, identifying the need to use persuasion to reduce ambiguity, and to adapt to multi-level policymaking systems.We identify insights from secondary data, namely systematic reviews, critical analysis and policy theories relevant to evidence-based policymaking. The studies are drawn primarily from countries such as the United States, United Kingdom, Canada, Australia and New Zealand. We combine empirical and normative elements to identify the ways in which scientists can, do and could influence policy.We identify two important dilemmas, for scientists and researchers, that arise from our initial advice. First, effective actors combine evidence with manipulative emotional appeals to influence the policy agenda – should scientists do the same, or would the reputational costs outweigh the policy benefits? Second, when adapting to multi-level policymaking, should scientists prioritise ‘evidence-based’ policymaking above other factors? The latter includes governance principles such the ‘co-production’ of policy between local public bodies, interest groups and service users. This process may be based primarily on values and involve actors with no commitment to a hierarchy of evidence.We conclude that successful engagement in ‘evidence-based policymaking’ requires pragmatism, combining scientific evidence with governance principles, and persuasion to translate complex evidence into simple stories. To maximise the use of scientific evidence in health and public health policy, researchers should recognise the tendency of policymakers to base judgements on their beliefs, and shortcuts based on their emotions and familiarity with information; learn ‘where the action is’, and be prepared to engage in long-term strategies to be able to influence policy; and, in both cases, decide how far you are willing to go to persuade policymakers to act and secure a hierarchy of evidence underpinning policy. These are value-driven and political, not just ‘evidence-based’, choices.
机译:关于“证据与政策的差距”,有大量的卫生和公共卫生文献,探讨了科学家试图确保对他们提出的问题和解决方案做出回应的令人沮丧的经验,并确定了需要更好的证据来减少决策者的不确定性。我们通过运用政策理论提出更具影响力的研究提出新的观点,确定有必要使用说服力来减少歧义并适应多层次的决策系统。我们从辅助数据中识别见解,即系统评价,批判性分析和与基于证据的决策相关的政策理论。这些研究主要来自美国,英国,加拿大,澳大利亚和新西兰等国家。我们结合经验和规范因素来确定科学家可以,采取和影响政策的方式。我们确定了科学家和研究人员的两个重要难题,这是我们最初的建议引起的。首先,有效的参与者将证据与操纵性的情感诉求相结合,以影响政策议程–科学家应该这样做还是声誉成本超过政策利益?其次,在适应多层次决策时,科学家是否应该优先考虑“基于证据”的决策,而不要考虑其他因素?后者包括治理原则,例如地方公共机构,利益集团和服务使用者之间的“共同生产”政策。该过程可能主要基于价值,并且涉及行为者,但不承诺证据层次。我们得出结论,成功参与“基于证据的决策”需要务实,将科学证据与治理原则相结合,并具有说服力将复杂证据转化为简单证据故事。为了最大程度地在卫生和公共卫生政策中使用科学证据,研究人员应认识到决策者倾向于根据自己的信念做出判断,并根据自己的情感和对信息的熟悉程度做出捷径。学习“行动在哪里”,并准备参与长期战略以影响政策;在这两种情况下,都要决定您愿意说服决策者采取何种行动并确保形成支持政策的证据层次。这些都是价值驱动的政治选择,而不仅仅是“基于证据的”选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号